|
1
|
Hanahan D and Weinberg RA: Hallmarks of
cancer: next generation. Cell. 144:646–674. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Blum HE: Hepatocellular carcinoma: therapy
and prevention. World J Gastroenterol. 11:7391–7400.
2005.PubMed/NCBI
|
|
3
|
Dunn L and Demichele A: Genomic predictors
of outcome and treatment response in breast cancer. Mol Doagn Ther.
13:73–90. 2009. View Article : Google Scholar
|
|
4
|
Woo HG, Park ES, Cheon JH, et al: Gene
expression-based recurrence prediction of hepatitis B virus-related
human hepatocellular carcinoma. Clin Cancer Res. 14:2056–2064.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Ge X, Yamamoto S, Tsusumi S, et al:
Interpreting expression profiles of cancers by genome-wide survey
of breath expression in normal tissues. Genomics. 86:127–141. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Chuma M, Sakamoto M, Yamazaki K, et al:
Expression profiling in multistage hepatocarcinogenesis:
identification of HSP70 as a molecular marker of early
hepatocellular carcinoma. Hepatology. 37:198–207. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Nojima M, Maruyama R, Yasui H, et al:
Genomic screening of genes silenced by DNA methylation revealed an
association between RASD1 inactivation and dexamethasone resistance
in multiple myeloma. Clin Cancer Res. 15:4356–4364. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Lee JS, Grisham JW and Thorgeirsson SS:
Comparative functional genomics for identifying models of human
cancer. Carcinogenesis. 26:1013–1020. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Farber E: Pre-cancerous steps in
carcinogenesis. Their physiological adaptive nature. Biochim
Biophys Acta. 738:171–180. 1984.PubMed/NCBI
|
|
10
|
Carrasco-Legleu CE, Márquez-Rosado L,
Fattel-Fazenda S, et al: Chemoprotective effect of caffeic acid
phenethyl ester on promotion in a medium-term rat
hepatocarcinogenesis assay. Int J Cancer. 108:488–492. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Marche-Cova A, Fattel-Fazenda S,
Rojas-Ochoa A, et al: Follow-up of GST-p during
hepatocarcinogenesis with DEN-2AAF in F344 rats. Arch Med Res.
26:S169–S173. 1995.PubMed/NCBI
|
|
12
|
Rutemburg AM, Kim H, Fischbein JW, et al:
Histochemical and structural demonstration of gamma-glutamyl
transpeptidase activity. J Histochem Cytochem. 17:517–526. 1969.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Thorgeirsson SS and Grisham JW: Molecular
pathogenesis of human hepatocellular carcinoma. Nat Genet.
31:339–346. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Lee JS, Chu IS, Heo J, et al:
Classification and prediction of survival in hepatocellular
carcinoma by gene expression profiling. Hepatology. 40:667–676.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Feitelson MA, Pan J and Lian Z: Early
molecular and genetic determinants of primary liver malignancy.
Surg Clin North Am. 84:339–354. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Enomoto K and Farber E: Kinetics of
phenotypic maturation of remodeling of hyperplastic nodules during
liver carcinogenesis. Cancer Res. 42:2330–2335. 1982.PubMed/NCBI
|
|
17
|
Tatematsu M, Nagamine Y and Farber E:
Redifferenciation as a basis for remodeling of carcinogen-induced
hepatocyte nodules to normal appearing liver. Cancer Res.
1:5049–5058. 1983.
|
|
18
|
Farber E: Experimental induction of
hepatocellular carcinoma as paradigm for carcinogenesis. Clin
Physiol Biochem. 5:152–159. 1987.PubMed/NCBI
|
|
19
|
Pérez-Carreón JI, López-García C,
Fattel-Fazenda S, et al: Gene expression profile related to the
progression of preneoplastic nodules toward hepatocellular
carcinoma in rats. Neoplasia. 8:373–383. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Borel F, Han R, Visser A, et al: Adenosine
triphosphate-binding cassette transporter genes up-regulation in
untreated hepatocellular carcinoma is mediated by cellular micro
RNAs. Hepatology. 55:821–832. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Nies AT, König J, Pfannschmidt M, et al:
Expression of the multidrug resistance proteins MRP2 and MRP3 in
human hepatocellular carcinoma. Int J Cancer. 94:492–499. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Serrano MA, Macias RI, Briz O, et al:
Expression in human trophoblast and choriocarcinoma cell lines,
BeWo, Jeg-3 and JAr of genes involved in the hepatobiliary-like
excretory function of the placenta. Placenta. 28:107–117. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Mizukoshi E, Honda M, Arai K, et al:
Expression of multidrug resistance-associated protein 3 and
cytotoxic T cell responses in patients with hepatocellular
carcinoma. J Hepatol. 49:946–954. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Nonaka M, Ma BY, Imaeda H, et al:
Dendritic cell-specific intercellular adhesion molecule 3-grabbing
non-integrin (DC-SIGN) recognizes a novel ligand, Mac-2-binding
protein, characteristically expressed on human colorectal
carcinomas. J Biol Chem. 286:22403–22413. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Fukaya Y, Shimada H, Wang LC, Zandi E and
DeClerck YA: Identification of galectin-3-binding protein as a
factor secreted by tumor cells that atimulates interleukin-6
expression in the bone marrow stroma. J Biol Chem. 283:18573–18581.
2008. View Article : Google Scholar : PubMed/NCBI
|
